NSE ScannerOpen the scanner

Diversified & Other · Miscellaneous · NSE: AJOONI · data 2026-10-31

Ajooni Biotech Limited

₹2.87-2.05% on 30 OctHealth: Average 5.3/10
Feb 2026Low ₹2.87 · High ₹5.14-41.8%

In plain words

Price: 47.8% below its 52-week high of ₹5.5.

Delivery: 72.2% of traded shares were kept for delivery over the last 10 sessions, against 74.8% over the last 60.

Latest results: a net profit of ₹0 cr for the quarter ended Jun 2026 (-44.9% on the same quarter a year earlier).

A description of the data, not a recommendation.

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price
₹2.87
Market cap
₹52 cr
P/E
12.5
P/B
0.5
ROE
4.8%
ROCE
4.5%
Debt / equity
0.19
Dividend yield
0.00%
1-year return
-45.0%
52-week high
₹5.5
52-week low
₹2.68
Operating margin
2.1%

Growth

Revenue (last 12 months)₹215 cr
Net profit (last 12 months)₹4 cr
Sales growth, 3 years (yearly)34.6%
Profit growth, 3 years (yearly)56.6%

At a glance

Ownership
Moderate

Promoters 30.5% (+3.6 pts in a year), pledged 0.0%.

Valuation
Low

P/E 12.5, P/B 0.5, dividend yield 0.0%. Price relative to earnings and book value (low is cheaper, not better).

Efficiency
Weak

ROE 4.8%, ROCE 4.5%, operating margin 2.1%: how much profit it earns on the money it uses.

Financials
Strong

Debt/equity 0.19, Profit growth 56.6% and sales growth 34.6% a year over 3 years.

Ratings use fixed thresholds on the latest reported figures. They describe the numbers and are not a recommendation.

Strengths and limitations

Strengths
  • Profit grew 56.6% a year over 3 years.
  • Promoters raised their holding by 3.6 points in a year.
Limitations
  • Low return on equity (4.8%).
  • Thin operating margin (2.1%).

Picked automatically from the latest reported figures with fixed rules; check the company's filings before relying on them.

Latest results in brief (Q1 FY27)

AJOONI Q1 FY27 results (standalone figures, as filed on NSE).

Revenue was ₹63.49 crore, up 103% YoY and up 4.7% QoQ.

Net profit was ₹0.43 crore, down 44.9% YoY and down 54.7% QoQ.

Operating margin was 2.6% (2.3% a year ago).

EPS was ₹0.01, down 50% YoY and down 50% QoQ.

AJOONI के Q1 FY27 नतीजे (स्टैंडअलोन आंकड़े, NSE पर दाखिल)।

राजस्व: ₹63.49 करोड़; पिछले साल की तुलना में 103% की बढ़त, पिछली तिमाही की तुलना में 4.7% की बढ़त।

शुद्ध मुनाफ़ा: ₹0.43 करोड़; पिछले साल की तुलना में 44.9% की गिरावट, पिछली तिमाही की तुलना में 54.7% की गिरावट।

ऑपरेटिंग मार्जिन: 2.6% (एक साल पहले 2.3%)।

EPS: ₹0.01; पिछले साल की तुलना में 50% की गिरावट, पिछली तिमाही की तुलना में 50% की गिरावट।

AJOONIના Q1 FY27 પરિણામો (સ્ટેન્ડઅલોન આંકડા, NSE પર ફાઇલ કરેલા).

આવક (રેવન્યુ): ₹63.49 કરોડ; ગયા વર્ષની સરખામણીએ 103% વધારો, ગયા ક્વાર્ટરની સરખામણીએ 4.7% વધારો.

ચોખ્ખો નફો: ₹0.43 કરોડ; ગયા વર્ષની સરખામણીએ 44.9% ઘટાડો, ગયા ક્વાર્ટરની સરખામણીએ 54.7% ઘટાડો.

ઓપરેટિંગ માર્જિન: 2.6% (એક વર્ષ પહેલાં 2.3%).

EPS: ₹0.01; ગયા વર્ષની સરખામણીએ 50% ઘટાડો, ગયા ક્વાર્ટરની સરખામણીએ 50% ઘટાડો.

Written from the filed numbers. Not a recommendation.

Smart-money activity

5/100 · Weak over the last ~60 sessions, data 2026-10-30

A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.

Story so far

2026-09-07: Bulk deal: ANANTHARAMAN JANAKI sold ₹0.38 cr2026-08-14: Q1 FY27 results: profit −44.9% YoY2026-05-28: Q4 FY26 results: profit −38.3% YoY

● Deal   ● Results

From official exchange filings and NSE data. How the price moved after an event describes the past, not what comes next.

Quarterly results (standalone)

QuarterRevenueNet profitProfit YoYOp. marginEPS ₹
Jun 2026₹63 cr₹0 cr-44.9%2.6%0.01
Mar 2026₹61 cr₹1 cr-38.3%1.7%0.05
Dec 2025₹59 cr₹2 cr+126.0%5.2%0.1
Sept 2025₹32 cr₹1 cr+50.0%4.7%0.08

Shareholding trend

HolderSept 2026Jun 2026Mar 2026Dec 2025
Promoters30.53%26.89%26.89%26.89%
Foreign institutions (FII)————
Domestic institutions (DII)————
Mutual funds————
Retail investors49.91%52.08%52.18%53.30%
Number of shareholders59,63360,67561,77962,699

Common questions

What was Ajooni Biotech Limited's latest quarterly profit?

Ajooni Biotech Limited reported a net profit of ₹0 cr for the quarter ended Jun 2026 (-44.9% on the same quarter a year earlier), on revenue of ₹63 cr.

How much do promoters hold in Ajooni Biotech Limited?

Promoters held 30.53% of Ajooni Biotech Limited at the end of Sept 2026, with 0.00% of promoter shares pledged.

Is Ajooni Biotech Limited debt-free?

Its latest reported debt-to-equity ratio is 0.19.

What is Ajooni Biotech Limited's P/E ratio?

About 12.5, based on the last 12 months' earnings and a price of ₹2.87 (data 2026-10-31).

What is the 52-week high and low of Ajooni Biotech Limited?

The 52-week high is ₹5.5 and the 52-week low is ₹2.68.

Compared with similar companies

CompanyPriceMarket capP/EP/BROEROCEDebt/eq.1-yr return
Ajooni Biotech Limited₹2.87₹52 cr12.50.54.8%4.5%0.19-45.0%
Ashika Global Securities Ltd₹379.95₹3,241 cr44.1—7.5%—0.33+2.1%
Shipping Corporation of India Land and Assets Limited₹34.88₹1,621 cr45.10.51%-0.5%0-32.5%
Univa Foods Limited₹9.48₹13 cr193.9——-224.9%—-26.7%

Compare AJOONI with ASHIKAG in detail →

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open AJOONI in NSE Scanner →
Share on WhatsAppShare on Telegram